FDA to convene expert panel on wider access to peptides
The agency's planned panel appeared in a Medical Economics roundup alongside unrelated health policy and fraud items.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 17 23:14 ETSource: Medical Economics
The wire
- 01Medical Economics reports that the FDA will convene an expert panel on broadening access to peptides.
- 02Any FDA move on peptide access bears directly on the compounding categories, bulk-substance lists and telehealth supply channels readers operate in.
- 03The item gives no date, panel membership or scope, and it is unclear which peptides or regulatory pathways would be covered.
From the source
Read at medicaleconomics.comTeam-based care model cuts blood pressure in high-risk populations; FDA to convene expert panel on wider access to peptides; Florida nursing assistant sentenced in $11.4M Medicare brace fraud scheme – Morning Medical Update
